April 2007
Archives of Disease in Childhood;Apr2007, Vol. 92 Issue 4, p369
Academic Journal
The article provides an overview of several studies that were published within the "Journal Watch Pediatrics and Adolescent Medicine." It is not appropriate to use adamantane drug for influenza. The use of selective serotonin reuptake inhibitors in pregnancy may affect the infant. Bariatric surgery is thought to be beneficial for morbidly obese postpubertal young adults.


Related Articles

  • Adverse effects of SSRIs taken during pregnancy. Thomas, Jack // Australian Journal of Pharmacy;Mar2010, Vol. 91 Issue 1078, p75 

    The article reports on the study that investigates the effect of intrauterine selective serotonin reuptake inhibitor (SSRI) exposure on pregnancy, which reveals that utero-exposed newborns had increased risk of admission to the neonatal intensive care unit.

  • SSRI use during pregnancy proliferating.  // PharmacoEconomics & Outcomes News;5/31/2008, Issue 554, p9 

    The article reports on the increase in use of selective serotonin reuptake inhibitors (SSRIs) in pregnancy between 1995 and 2004, according to a population-based cohort study from the Netherlands.

  • Treatment with SSRIs during pregnancy increased risk for preterm birth. Thomas, Jack // Australian Journal of Pharmacy;Aug2012, Vol. 93 Issue 1107, p88 

    The article presents information on the risk of Selective serotonin reuptake inhibitors (SSRIs) treatment during pregnancy.

  • Teratogenic risk of SSRIs used during pregnancy. Huffman, Grace Brooke // American Family Physician;7/1/1998, Vol. 58 Issue 1, p243 

    Presents a summary of the article `Pregnancy Outcome Following Maternal Use of the New Selective Serotonin Reuptake Inhibitors,' by N.A. Kulin and others, which was published in the February 25, 1998, issue of the `Journal of the American Medical Association.' Examination of the pregnancy...

  • Corrections.  // Archives of Disease in Childhood -- Fetal & Neonatal Edition;Mar2013, Vol. 98 Issue 2, pF180 

    A correction to the article "Maternal use of SSRIs, SNRIs and NaSSAs:Practical Recommendations During Pregnancy and Lactation" that was published in a previous issue of the journal is presented.

  • Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy: response. Jerome, Laurence; Jerome, L // Canadian Journal of Psychiatry;Jun2001, Vol. 46 Issue 5, p452 

    A response from the author of the article "Neurobiology of the use of selective serotonin reuptake inhibitors during pregnancy" which was published in a previous issue is presented.

  • Venlafaxine, SSRIs safe in early pregnancy.  // Reactions Weekly;May2015, Vol. 1549 Issue 1, p12 

    The article reports on the findings of a sibling-controlled cohort study which indicate that treatment with selective serotonin reuptake inhibitors and venlafaxine in early pregnancy does not cause cardiac or other birth defects.

  • SSRIs in pregnancy: risk of early infant morbidity and mortality.  // Reactions Weekly;7/14/2012, Issue 1410, p2 

    The article deals with a study conducted in Western Australia which revealed that morbidity and mortality in early years of life are increased by maternal use of selective serotonin re-uptake inhibitors (SSRIs) during pregnancy.

  • British Journal of Clinical Pharmacology.  // Biomedical Market Newsletter;3/28/2012, Vol. 21, p1 

    The article focuses on a research, according to which the use of selective serotonin re-uptake inhibitor antidepressants during pregnancy is linked with increased risk of pregnancy induced high blood pressure.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics